
Composition: Levocarnitine
Form: Solution for intravenous and intramuscular injection
Indications: Acute hypoxic conditions (stroke, TIA), traumatic brain injury (TBI), circulatory encephalopathy, toxic brain damage, post-surgery recovery, carnitine deficiency, cardiomyopathy, coronary artery disease, post-infarction conditions, cardiogenic shock.
Contraindications: Individual intolerance, pregnancy, lactation (no safety data), childhood.
Dosage: Usually 0.5–1 g (1–2 ampoules) IV or IM daily for 3–7 days. In acute cerebrovascular accident — 1 g/day for 3 days, then 0.5 g/day for 7 days. For hemodialysis — 2 g after the procedure. For infarction/shock — 3–5 g/day (6–10 ampoules).
Side effects: Allergic reactions, muscle weakness (in uremia), vein pain with rapid injection.
Interactions: Glucocorticoids enhance tissue accumulation (except in the liver), anabolic steroids enhance the effect.
Warnings: Prescribed by a doctor. Rapid injection may cause vein irritation. Switching to oral form after injections is possible.
Age restrictions: From 18 years old
Pregnancy: Contraindicated during pregnancy and breastfeeding.
Country of origin: Russia
Manufacturer: PIK-PHARMA
Storage conditions: Store in a place protected from light at 15–25 °C. Keep out of reach of children.
Doctor, 2018
Авторы: L. Chichanovskaya, O. Bahareva, K. Sorokina
Read❓ In which cases is Elcar administered intravenously?
💬 For strokes, cerebral ischemia, cardiomyopathy, hypoxia, carnitine deficiency, and rehabilitation after trauma or surgeries.
❓ Can Elcar be administered intramuscularly?
💬 Yes, it can be administered both intravenously and intramuscularly (depending on indications and patient's condition).